Brussels - Delayed Quote EUR

Sequana Medical NV (SEQUA.BR)

0.9600
+0.0400
+(4.35%)
At close: 5:35:10 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Ian Crosbie CEO & Executive Director 465.12k -- --
Ms. Kirsten Van Bockstaele Chief Financial Officer 361.31k -- 1975
Dr. Gijs Klarenbeek M.D. MD & Chief Medical Officer -- -- 1977
Mr. Martijn Blom Chief Commercial Officer -- -- 1974

Sequana Medical NV

Kortrijksesteenweg 1112
box 102 Sint-Denijs-Westrem
Gent, 9051
Belgium
32 9 292 8065 https://www.sequanamedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
48

Description

Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offers alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body. Sequana Medical NV was founded in 2006 and is headquartered in Gent, Belgium.

Corporate Governance

Sequana Medical NV’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

MOVE.SW Medacta Group SA
135.00
0.00%
 
EUZ.DE Eckert & Ziegler SE
66.75
+2.61%
 
PHIA.AS Koninklijke Philips N.V.
20.62
-0.10%
 
INSP Inspire Medical Systems, Inc.
136.79
+0.63%
 
CERS Cerus Corporation
1.4350
-4.97%
 
ARAY Accuray Incorporated
1.2900
0.00%
 
CATX Perspective Therapeutics, Inc.
3.2730
-1.56%
 
BFLY Butterfly Network, Inc.
2.4790
+0.16%
 
NNOX Nano-X Imaging Ltd.
5.61
+1.36%